Panacea Biotec Limited announced earnings results for the first quarter ended June 30, 2021. For the first quarter, the company announced total revenue was INR 1,356.8 million compared to INR 1,339.5 million a year ago. Net loss was INR 573.5 million compared to INR 341.3 million a year ago. Basic loss per share from continuing operations was INR 9.36 compared to INR 5.41 a year ago. Diluted eps - continuing operations was INR 0 compared to diluted loss per share from continuing operations of INR 0.17 a year ago.